(Q34202505)

31 July 2017

title

Optical nanomanipulations of malignant cells: controlled cell damage and fusion (English)

1 reference

31 July 2017

Limor Minai

1

1 reference

31 July 2017

Daniella Yeheskely-Hayon

2

1 reference

31 July 2017

Lior Golan

3

1 reference

31 July 2017

Gili Bisker

4

1 reference

31 July 2017

Eldad J Dann

5

1 reference

31 July 2017

Dvir Yelin

6

1 reference

31 July 2017

language of work or name

1 reference

19 March 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

1732-1739

1 reference

Photodynamic therapy of cancer: an update

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Nanoshell-enabled photothermal cancer therapy: impending clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Laser-Activated Gene Silencing via Gold Nanoshell-siRNA Conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

A quantitative study on the photothermal effect of immuno gold nanocages targeted to breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Gold Nanorods Mediate Tumor Cell Death by Compromising Membrane Integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Laser-induced tissue hyperthermia mediated by gold nanoparticles: toward cancer phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Comparative study of photothermolysis of cancer cells with nuclear-targeted or cytoplasm-targeted gold nanospheres: continuous wave or pulsed lasers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Selective photothermal efficiency of citrate capped gold nanoparticles for destruction of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Cancer-cell microsurgery using nonlinear optical endomicroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Pulsed-laser creation and characterization of giant plasma membrane vesicles from cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

PEG as a tool to gain insight into membrane fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Electric field-mediated fusion and related electrical phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Exploiting different ways to die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Stimulation of anti-tumor immunity by photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Repertoire of antiviral antibodies expressed by somatic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Laser induced cell fusion in combination with optical tweezers: The laser cell fusion trap

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Femtosecond laser-induced fusion of nonadherent cells and two-cell porcine embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

Gold nanoparticles capped by peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

A dominant-negative form of POM121 binds chromatin and disrupts the two separate modes of nuclear pore assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201102304

21 January 2018

Identifiers

DOI

10.1002/SMLL.201102304

1 reference

31 July 2017

1 reference